Who Paid My Doc
Commence Study 2012-02
Research payments
$8,139,767
Through program year 2025, $8,139,767 in research payments was reported against Commence Study 2012-02, across 662 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $931,689 | 44 |
| 2024 | Research | $1,694,252 | 50 |
| 2023 | Research | $835,804 | 185 |
| 2022 | Research | $981,765 | 69 |
| 2021 | Research | $900,045 | 84 |
| 2020 | Research | $1,034,019 | 91 |
| 2019 | Research | $1,762,193 | 139 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Douglas Johnston Chicago, IL Named on 107 payments
- Joseph Bavaria Philadelphia, PA Named on 75 payments
- Bartley Griffith Baltimore, MD Named on 32 payments
- Hiroo Takayama New York, NY Named on 23 payments
- Venugopal Menon Chapel Hill, NC Named on 22 payments
- David Heimansohn Carmel, IN Named on 19 payments
- Marijan Koprivanac Philadelphia, PA Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.